Now, several publications and presentations at the recent Alzheimer’s Association International Conference have demonstrated that blood tests measuring amyloid and tau proteins have become much more ...
These various tests are at different stages of validation – assuring they’re accurate across many different populations. And, for each protein, there are several different met ...
The unnamed 44-year-old from the south of France started feeling a mild pain in his leg, which prompted him to visit his ...
Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...
A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving early Alzheimer’s diagnosis. Unlike amyloid-beta, tau neurofibrillary ...
A blood test to detect the early signs of a type of dementia before it develops will be trialled across the UK in a study led ...
People who sit on the low or high side of normal vitamin B12 levels are still at risk of cognitive impairment, according to a ...
More than 2 years since the original trial data for lecanemab in Alzheimer's disease was published,1 and over 1·5 years since approval by the US Food and Drug Administration, brain volume data have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback